Drug details

Purinethol (mercaptopurine)

type of Immunomodulators, Antineoplastics, Antimetabolite

Purinethol (mercaptopurine) is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body used to treat acute lymphatic leukemia or acute myelogenous leukemia. Purinethol is usually given together with other cancer medications. Purinethol is available in generic form.

This drug may have the following side effects:

• nausea,
• vomiting,
• diarrhea,
• loss of appetite,
• itching or skin rash, or
• darkened skin color.

The following drugs are related to Purinethol, either as a replacement or used together:

• Otezla (apremilast tablets)
• Asacol (mesalamine delayed-release tablets)
• Erwinaze (asparaginase erwinia chrysanthemi)
• YESCARTA (axicabtagene ciloleucel suspension for intravenous infusion)
• Azulfidine EN-Tabs (sulfasalazine delayed release tablets)
• Colazal (balsalazide)
• Bosulif (bosutinib tablets)
• Cerubidine (daunorubicin)
• Dipentum (olsalazine sodium capsules)
• Engerix-B (hepatitis b vaccine recombinant)
• Fludara (fludarabine)
• Gleevec (imatinib mesylate)
• Idamycin (idarubicin)
• Idamycin PFS (idarubicin hydrochloride injection)
• Jakafi (ruxolitinib)
• Lialda (mesalamine)
• Pentasa (mesalamine)
• Rituxan Hycela (rituximab and hyaluronidase human injection)

The following supplements are related to Purinethol, and may be used together with the drug:

• Saccharomyces Boulardii (s.)
• Arsenic (s.)
• Transfer Factor (s.)